搜索筛选:
搜索耗时0.2455秒,为你在为你在84,890,000篇论文里面共找到 63 篇相符的论文内容
类      型:
[期刊论文] 作者:GAO Run-lin, 来源:中华医学杂志(英文版) 年份:2004
Drug-eluting stent (DES) has markedly reduced restenosis and the need for target lesion revascularization (TLR). The safety profile of DES does not seem to diff...
[期刊论文] 作者:GAO Run-lin, 来源:中华医学杂志英文版 年份:2006
[期刊论文] 作者:GAO Run-lin, 来源:中华医学杂志(英文版) 年份:2008
Reperfusion therapy including primary percutaneous coronary intervention (PCI) and thrombolytic therapy has become the most important strategy for the treatmen...
[期刊论文] 作者:LI Jian-jun,GAO Run-lin, 来源:中华医学杂志(英文版) 年份:2009
Coronary stents have been used as standard mechanical devices for percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD).1-3 T...
[期刊论文] 作者:LI Chong-jian,GAO Run-lin,YANG, 来源:中华医学杂志(英文版) 年份:2004
Approximately 15%-20% of the patients undergoing percutaneous coronary intervention (PCI) procedure complicate with diabetes and this patient population continu...
[期刊论文] 作者:LI Chong-jian,GAO Run-lin,YANG, 来源:中华医学杂志(英文版) 年份:2005
Approximately 15%-20% of the patients undergoing percutaneous coronary intervention (PCI) procedure complicate with diabetes and this patient population contin...
[期刊论文] 作者:GAO Run-lin,XU Bo,CHEN Ji-lin,, 来源:中华医学杂志(英文版) 年份:2004
Background In response to the increasing concem with the safety of the drug-eluting stent (DES), the present study aimed to evaluate the long-term safety and ef...
[期刊论文] 作者:GAO Run-lin,HAN Ya-ling,YANG X, 来源:中华医学杂志(英文版) 年份:2004
Background Although thrombolytic therapy with rescue percutaneous coronary intervention (PCI) is a common treatment strategy for ST-segment elevation acute myoc...
[期刊论文] 作者:CHEN Ji-lin,GAO Run-lin,YANG Y, 来源:中华医学杂志(英文版) 年份:2004
Background Because no large prospective studies are available, this study evaluated the clinical outcomes of two drug eluting stents in bifurcation lesions.Meth...
[期刊论文] 作者:CHEN Ji-lin,GAO Run-lin,YANG Y, 来源:中华医学杂志(英文版) 年份:2004
Background Drug-eluting stent (DES) could obviously reduce in-stent restenosis, which has been proved by international multi-center clinical trials. However, th...
[期刊论文] 作者:XU Lian-jun,GAO Run-lin,WU Cha, 来源:中华医学杂志(英文版) 年份:2012
Background Dicycloplatin is a relatively safe third generation platinum-complex anti-cancer drug.The present study focused on the effects of dicycloplatin on in...
[期刊论文] 作者:GAO Run-lin,HAN Ya-ling,YANG X, 来源:中华医学杂志(英文版) 年份:2010
Background Although thrombolytic therapy with rescue percutaneous coronary intervention (PCI) is a common treatment strategy for ST-segment elevation acute myoc...
[期刊论文] 作者:GAO Run-lin,XU Bo,Martin B.Leo, 来源:中华医学杂志(英文版) 年份:2013
[期刊论文] 作者:XU Bo,GAO Run-lin,ZHANG Rui-ya, 来源:中华医学杂志(英文版) 年份:2013
Background Previous studies indicated that long coronary lesions are one of the key predictors of drug-eluting stent (DES) failure.The purpose of this study was...
[期刊论文] 作者:GAO Run-lin,CHEN Ji-lin,YANG Y, 来源:中华医学杂志(英文版) 年份:2006
Background The long term prognosis of unprotected left main coronary artery (LMCA) stenting is controversial This study was conducted to evaluate the immediate...
[期刊论文] 作者:CHEN Ji-lin,GAO Run-lin,YANG Y, 来源:中华医学杂志(英文版) 年份:2006
Background Drug-eluting stent (DES) could obviously reduce in-stent restenosis, which has been proved by intational multi-center clinical trials. However, the t...
[期刊论文] 作者:GAO Run-lin,XU Bo,CHEN Ji-lin,, 来源:中华医学杂志(英文版) 年份:2009
Background In response to the increasing concem with the safety of the drug-eluting stent (DES), the present study aimed to evaluate the long-term safety and ef...
[会议论文] 作者:QIU Hong,GAO Run-lin,FAN De-zeng, 来源:中国介入心脏病学大会(CIT2007) 年份:2007
[会议论文] 作者:YUAN Jin-qing,XU Bo,GAO Run-lin, 来源:中国介入心脏病学大会(CIT2007) 年份:2007
[会议论文] 作者:QIU Hong,GAO Run-lin,XU Bo, 来源:2008年中国介入心脏病学大会 年份:2008
相关搜索: